Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Radiosurgery × Other solid neoplasm × Clear all

Phase

Status

Completed 4 Terminated 3 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 45 CNS 30 Thoracic 26 Gastrointestinal 24 Breast 16 Dermatologic 11 Tumor-Agnostic 7 Head & Neck 6 Sarcoma 4 Other hematologic neoplasm 2 Gynecologic 2 Other solid neoplasm 1 NET 1 Lymphoid 1 Endocrine 1

Conditions

Oligometastatic Disease 1

Interventions

Injections 41 pembrolizumab 36 Bevacizumab 20 Carboplatin 19 Cyclophosphamide 16 Cisplatin 13 tislelizumab 12 fludarabine 12 Paclitaxel 12 Nivolumab 11 Specimen Handling 10 Cetuximab 10 toripalimab 9 Oxaliplatin 9 Interviews as Topic 9 Fluorouracil 9 atezolizumab 8 Standard of Care 8 Practice Guidelines as Topic 8 Pemetrexed 8 Docetaxel 8 Leucovorin 7 Capecitabine 7 spartalizumab 6 olaparib 6 Educational Status 6 palbociclib 5 lenvatinib 5 Irinotecan 5 Ipilimumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06439888 2025-12-01

LySATRA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Other solid neoplasm

Oligometastatic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡